被 发 现 含 有 未 标 示 西 药 的 产 品
|
| |
| The United States: HON-E-LING may be harmful due to hidden drug ingredients (English only) |
| |
The United States Food and Drug Administration (FDA) is advising consumers not to purchase or use HON-E-LING, a product promoted for sexual enhancement on various websites, and possibly in some retail stores. This product was identified during an examination of imported goods.
FDA laboratory analysis confirmed that HON-E-LING contains sibutramine and sildenafil, which are not listed on the product label.
Sibutramine has been used in the management of obesity and is a controlled substance that was removed from the market in October 2010 for safety reasons. This product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or heart rate in some people and may present a significant risk for people with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke. This product may also interact, in life-threatening ways, with other medications a consumer may be taking.
Sildenafil is the active ingredient in the FDA-approved prescription drug Viagra, used to treat erectile dysfunction. FDA approval of Viagra is restricted to use under the supervision of a licensed health care professional. This undeclared ingredient may interact with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels. People with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates.
Please refer to the following website in FDA for details:
http://www.fda.gov/drugs/medication-health-fraud/hon-e-ling-may-be-harmful-due-hidden-drug-ingredients
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Wednesday, Nov 20, 2024
Issued at HKT 15:30
|
| |
